Cargando…
Artefenomel Regioisomer RLA-3107 Is a Promising Lead for the Discovery of Next-Generation Endoperoxide Antimalarials
[Image: see text] Clinical development of the antimalarial artefenomel was recently halted due to formulation challenges stemming from the drug’s lipophilicity and low aqueous solubility. The symmetry of organic molecules is known to influence crystal packing energies and by extension solubility and...
Autores principales: | Blank, Brian R., Gut, Jiri, Rosenthal, Philip J., Renslo, Adam R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108391/ https://www.ncbi.nlm.nih.gov/pubmed/37077383 http://dx.doi.org/10.1021/acsmedchemlett.3c00039 |
Ejemplares similares
-
Enantioselective
Synthesis and in Vivo Evaluation
of Regioisomeric Analogues of the Antimalarial Arterolane
por: Blank, Brian R., et al.
Publicado: (2017) -
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
por: Phyo, Aung Pyae, et al.
Publicado: (2016) -
RLA design: RF optics
por: Verdier, A
Publicado: (2001) -
The Role of the Iron Protoporphyrins Heme and Hematin in the Antimalarial Activity of Endoperoxide Drugs
por: Quadros, Helenita C., et al.
Publicado: (2022) -
Monoclonal Antibodies That Recognize the Alkylation
Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel)
por: Jourdan, Joëlle, et al.
Publicado: (2015)